Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.64 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | FYN | P06241 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PEPD | P12955 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28687203 | 0.93 | SLC34A1 (0.53) | SLC34A1FFAR3LCKFYNCA4 | |
| Phosphoric Acid SCHEMBL27543550 | 0.93 | SLC34A1 (0.53) | SLC34A1FFAR3LCKFYNCA4 | |
| Phosphoric Acid SCHEMBL4743959 | 0.93 | SLC34A1 (0.53) | SLC34A1FFAR3LCKFYNCA4 | |
| Phosphoric Acid SCHEMBL29192758 | 0.93 | SLC34A1 (0.53) | SLC34A1FFAR3LCKFYNCA4 | |
| Phosphoric Acid SCHEMBL29261810 | 0.93 | SLC34A1 (0.53) | SLC34A1FFAR3LCKFYNCA4 | |
| Phosphoric Acid SCHEMBL10690616 | 0.90 | SLC34A1 (0.50) | SLC34A1FFAR3LCKFYNCA4 | |
| Phosphoric Acid SCHEMBL28247418 | 0.90 | SLC34A1 (0.50) | SLC34A1FFAR3LCKFYNCA4 | |
| Phosphoric Acid SCHEMBL2467383 | 0.89 | FFAR3 (0.54) | SLC34A1FFAR3LCKFYNCA4 | |
| Phosphoric Acid SCHEMBL10379778 | 0.88 | SLC34A1 (0.50) | SLC34A1FFAR3LCKFYNCA4 | |
| Phosphoric Acid SCHEMBL2785579 | 0.88 | CA1 (0.50) | SLC34A1FFAR3LCKFYNCA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108451901-A | A kind of preparation of azacitidine and preparation method thereof | 宁波蒙曼生物科技有限公司 | 2018-08-28 | — | — | CN | claimed |
| CN-119355163-A | Paeonia lactiflora and embolic skin fermentation liquor for exerting anti-inflammatory drug effect substance basic components and analysis method | 佳木斯大学 | 2025-01-24 | — | — | CN | disclosed |
| CN-113973821-B | Drought-resistant agent and method for improving drought resistance of plants | 广东省科学院南繁种业研究所 | 2023-03-31 | — | — | CN | disclosed |
| CN-114249749-A | Conversion method of marbofloxacin formate | 天象生物药业邢台有限责任公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-113973821-A | Drought-resistant agent and method for improving drought resistance of plants | 广东省科学院南繁种业研究所 | 2022-01-28 | — | — | CN | disclosed |
| CN-107250435-A | Aluminum or aluminum alloy chemical synthesis treatment liquid, formation processing method and chemical conversion envelope | 奥野制药工业株式会社 | 2017-10-13 | — | — | CN | disclosed |
| CN-105363017-A | Composition containing polymyxin B and preparation method thereof | BEIJING TIDE PHARMACEUTICAL CO LTD | 2016-03-02 | — | — | CN | disclosed |
| CN-101624585-A | Extraction method of prolease in swine stomach | LIPING ZHANG | 2010-01-13 | — | — | CN | disclosed |